New way to deliver chemo may help mesothelioma patients avoid surgery
NCT ID NCT05449366
First seen Oct 31, 2025 · Last updated May 12, 2026 · Updated 26 times
Summary
This study tested a chemotherapy drug (paclitaxel) given directly into the abdomen for people with a rare cancer called malignant peritoneal mesothelioma. The 7 participants could not or chose not to have standard surgery. The main goal was to find the safest dose and see if the treatment is feasible. The approach aims to control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL MALIGNANT MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Erasmus Medical Center
Rotterdam, South Holland, 3000 CA, Netherlands
Conditions
Explore the condition pages connected to this study.